Connect with us

Press Releases

Dopavision Appoints Dr. Dirk Sauer as Chair of the Company’s Advisory Board

Former head of Novartis’ Ophthalmology Development Unit to provide significant product development expertise and industry network.




(PRESS RELEASE) BERLIN, GERMANY — Dopavision, a clinical-stage company pioneering the development of digital therapeutics, announced the appointment of Dr. Dirk Sauer as chairman of the Company’s Advisory Board. Dirk Sauer brings an exceptional track record in the development of ophthalmic therapeutics and an extensive industry network to advance MyopiaX, Dopavision’s leading-edge digital therapeutic for childhood myopia control. MyopiaX is currently in clinical trials in Germany, Portugal, Spain, and Ireland.

Dirk Sauer is an expert in eye therapeutics development with long-standing global experience in ophthalmology and neuroscience. At Novartis Pharma, he successfully led numerous projects and teams during all phases of the drug development process and was, among others, responsible for the development of ophthalmology therapies to treat the wet form of macular degeneration. Furthermore, he led the company’s Ophthalmology Development Unit as Global Development Unit Head for more than nine years. During that time, he built a development portfolio in various ocular indications, spanning from small molecules to biologics, gene therapies, and digital therapeutics. His leadership included the development unit of the former Alcon Pharma franchise.

“Dirk brings extremely valuable knowledge in both research and product development,” said Mark Wuttke, CEO of Dopavision. “He is familiar with a wealth of indications affecting both back and front of the eye, the selection of the best approaches and the challenges of bringing them to market. He will be a great addition to our Advisory Board and will provide leadership for the entire R&D team.”

“I am really excited to chair Dopavision’s Advisory Board,” said Dr. Dirk Sauer. “The Company has developed an outstanding technology to combat childhood myopia, a very pressing global health problem. I am very happy to contribute to the success of this entirely new concept – a true digital approach to treat eye disease.”


Turn Patients Into Loyal Eyewear Shoppers

80% of patients are browsing eyewear online, are you influencing patients online before your competition? Join thousands of practices thriving with Optify, voted the #1 optical sales tool by EyeVote. Empower your opticians to save time, increase optical revenue, and maximize your EHR data and website with a seamless optical plug-in that keeps patients buying from YOU! Now through August 31st receive a $25 UberEats® gift card when you complete a 15 min demo. Book your demo here..

Promoted Headlines





Get the most important news and business ideas for eyecare professionals every weekday from INVISION.



Most Popular

Link partner: indobet autowin88 vegasslot77 mantra88 ligasedayu warungtoto login sbobet vegas4d indobet ingatbola88 ligaplay dewagg hoki368 qqnusa ligagg zeus138 bro138 bos88 ligaciputra